Invicta Launches Inflammation Diagnostic For Horses - EquiChek

Invicta Animal Health has been appointed exclusive UK distributor of EquiChek^TM. EquiChek is a novel rapid screening test, using whole blood, to assess the level of Serum Amyloid A (SAA) which is a major acute phase protein of inflammation in horses. Importantly, EquiChek is the first test which is able to provide a visual semi-quantitative result within 15 minutes. The test will display 4 lines for a normal level of SAA and sequentially fewer lines depending on the severity of the inflammation. Rob Watkins, Managing Director of Invicta, said “Monitoring SAA levels in horses is a well documented method of indicating a variety of conditions and for assessing health/inflammatory status prior to performance. However, the needs for equipment and time to perform the tests have always limited the situations in which it can be used. EquiChek changes all that. A stableside test for SAA means that monitoring real-time becomes a reality. Whether for tailoring antibiotic therapy, to check pre-breeding health status through to pre-competition health assessment, the applications are literally endless”. EquiChek adds to the Invicta portfolio of equine products, SynVet-50 and CST conditioned serum kits. For further information see www.invictavet.com or phone 01403 791313

More from

• IVC Evidensia assembles expert team to run new £10m referral hospital
• Home delivery service can increase pet health plan sign-ups by 25%
• Research reveals vital clues to help fight anthelmintic resistance
• Lifetime Achievement Award recognises Harrogate vet’s dedication to improving the health and welfare of rabbits
• Bake sale at Leicestershire vet practice for good cause